SE420731B - Sett att framstella 5-androsten-17-on-derivat - Google Patents

Sett att framstella 5-androsten-17-on-derivat

Info

Publication number
SE420731B
SE420731B SE7608575A SE7608575A SE420731B SE 420731 B SE420731 B SE 420731B SE 7608575 A SE7608575 A SE 7608575A SE 7608575 A SE7608575 A SE 7608575A SE 420731 B SE420731 B SE 420731B
Authority
SE
Sweden
Prior art keywords
androsten
derivatives
make
Prior art date
Application number
SE7608575A
Other languages
English (en)
Other versions
SE7608575L (sv
Inventor
A Weber
M Kennecke
A Popper
R Muller
U Eder
G Haffer
G Sauer
G Neef
R Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE7608575L publication Critical patent/SE7608575L/sv
Publication of SE420731B publication Critical patent/SE420731B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/003—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/005—Degradation of the lateral chains at position 17
SE7608575A 1975-08-01 1976-07-29 Sett att framstella 5-androsten-17-on-derivat SE420731B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2534911A DE2534911C2 (de) 1975-08-01 1975-08-01 Verfahren zur Herstellung von 5-Androsten-17-on-Derivaten

Publications (2)

Publication Number Publication Date
SE7608575L SE7608575L (sv) 1977-02-02
SE420731B true SE420731B (sv) 1981-10-26

Family

ID=5953265

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7608575A SE420731B (sv) 1975-08-01 1976-07-29 Sett att framstella 5-androsten-17-on-derivat

Country Status (17)

Country Link
US (1) US4170518A (sv)
JP (1) JPS5238090A (sv)
AT (1) AT361639B (sv)
BE (1) BE844745A (sv)
CH (1) CH624415A5 (sv)
CS (1) CS191981B2 (sv)
DD (3) DD131561A5 (sv)
DE (1) DE2534911C2 (sv)
DK (1) DK140172C (sv)
FR (1) FR2319650A1 (sv)
GB (1) GB1576129A (sv)
HU (1) HU183019B (sv)
IE (1) IE44308B1 (sv)
IT (1) IT1065955B (sv)
NL (1) NL7608540A (sv)
SE (1) SE420731B (sv)
SU (1) SU697053A3 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2632677A1 (de) * 1976-07-16 1978-01-26 Schering Ag Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
IL108371A (en) * 1993-01-19 2009-09-01 Endorech Inc Use of sex steroid precursors to prepare medicaments for treatment of vaginal atrophy
US6117429A (en) * 1997-08-11 2000-09-12 Weider Nutrition International, Inc Compositions and treatments for reducing potential unwanted side effects associated with long-term administration of androgenic testosterone precursors
EP1149839A1 (en) * 2000-04-28 2001-10-31 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. Progesterone substantially free of delta14-pregnene-3,20-dione
KR100432054B1 (ko) * 2001-05-11 2004-05-17 (주)유진사이언스 스테롤로부터 4-안드로스텐-3,17-디온/안드로스타-1,4-디엔-3,17-디온으로의 뛰어난 전환능을 가지는 미생물 및 이의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione

Also Published As

Publication number Publication date
IE44308B1 (en) 1981-10-21
SU697053A3 (ru) 1979-11-05
DE2534911C2 (de) 1985-04-18
DD127114A5 (sv) 1977-09-07
SE7608575L (sv) 1977-02-02
JPS6253160B2 (sv) 1987-11-09
HU183019B (en) 1984-04-28
BE844745A (fr) 1977-01-31
GB1576129A (en) 1980-10-01
CS191981B2 (en) 1979-07-31
ATA565676A (de) 1980-08-15
IT1065955B (it) 1985-03-04
IE44308L (en) 1977-02-01
DK140172B (da) 1979-07-02
NL7608540A (nl) 1977-02-03
US4170518A (en) 1979-10-09
JPS5238090A (en) 1977-03-24
DE2534911A1 (de) 1977-02-17
DD131561A5 (de) 1978-07-05
FR2319650A1 (fr) 1977-02-25
CH624415A5 (sv) 1981-07-31
DK140172C (da) 1979-11-26
DD131562A5 (de) 1978-07-05
DK343976A (da) 1977-02-02
FR2319650B1 (sv) 1980-05-09
AT361639B (de) 1981-03-25

Similar Documents

Publication Publication Date Title
SE433222B (sv) Sett att framstella modifierad polysackarid
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE422077B (sv) Sett att framstella syntesgas
SE426583B (sv) Sett att framstella etylidenacetat
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE7606280L (sv) Sett att framstella etrar
SE7600277L (sv) Sett att framstella sampolymerisatpulver
SE433492B (sv) Sett att framstella fenylettiksyraderivat
SE7612532L (sv) Sett att framstella grundpalar
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE425736B (sv) Sett att framstella kromanon-(4)
SE427111B (sv) Sett att framstella pilokarpiniumsalter
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE7608927L (sv) Sett att framstella pyridinderivat
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE424991B (sv) Sett att framstella nya 5-fenyl-oxazolidinoner
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE434397B (sv) Sett att framstella bens-acyl-bensimidazol-2-derivat
SE427655B (sv) Sett att framstella abietamidderivat
SE7607171L (sv) Sett att framstella indolokinoliziner
SE420731B (sv) Sett att framstella 5-androsten-17-on-derivat
SE7608939L (sv) Sett att framstella pyrrolinderivat
SE433213B (sv) Sett att framstella 2 -fenyl-3-amino-benso/b/tiofenderivat
SE420690B (sv) Sett att kontinuerligt framstella vermeisolerande ledningsror
SE412233B (sv) Sett att framstella nya fenotiazinderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7608575-2

Effective date: 19910211

Format of ref document f/p: F